Integrated Research Institute for Natural Ingredients and Functional Foods
Yangsan, 50612, South Korea
Location status: Recruiting
NCT Number: NCT03775837
The investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects of Panax Ginseng C.A. Mey Extract on liver function in adults for 8 weeks.
Interested in participating?
Request Info19 year–75 year
All sexes
Interventional
Not applicable
Yangsan, 50612, South Korea
Location status: Recruiting
Previous studies have indicated that Panax Ginseng C.A. Mey Extract may have the ability to improve liver function. Therefore, the investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects of the Panax Ginseng C.A. Mey Extract on liver function in adults; the safety of the compound are also evaluate. The Investigators examine AST, ALT, GGT, and other metabolic parameters at baseline, as well as after 4 and 8 weeks of intervention. Sixty adults were administered either 600 mg of Panax Ginseng C.A. Mey Extract or a placebo each day for 8 weeks;
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This group takes Panax Ginseng C.A. Mey Extract for 8 weeks
This group takes placebo for 8 weeks
Time frame: 8 weeks
Alanine aminotransferase
Time frame: 8 weeks
Aspartate aminotransferase
Time frame: 8 weeks
Gamma-glutamyl transferase
Contact information is provided by the study sponsor or research team.
Pusan National University Yangsan Hospital
Other
Effect of Panax Ginseng C.A. Mey Extract on Liver Function in Adults: a Randomized, Double-blinded, Placebo-controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04181138
Bile Duct Diseases, Biliary Tract Diseases
Los Angeles, California, United States
View Trial DetailsNCT06068491
Digestive System Diseases, Liver Diseases
Little Rock, Arkansas, United States
View Trial DetailsNCT06138821
Body Weight, Body Weight Changes
Boston, Massachusetts, United States
View Trial DetailsNCT07559474
Digestive System Diseases, Hemic and Lymphatic Diseases
Chandler, Arizona, United States
View Trial Details